Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Go back to Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.65 +0.12 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.53 | 52 Week High | $63.73 | |||
| Open | $17.82 | 52 Week Low | $8.00 | |||
| Day High | $18.18 | P/E | N/A | |||
| Day Low | $17.50 | EPS | $-5.69 | |||
| Volume | 2,354,968 | |||||
